SCHEMBL13036097

SCHEMBL13036097

Cc1ccc(F)c(-c2ccnn2C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
MAPT P10636 1/20 0.46
NISCH Q9Y2I1 1/20 0.44
SCN9A Q15858 2/20 0.43
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
TGFBR1 P36897 2/20 0.40
COMT P21964 1/20 0.40
CYP1A2 P05177 1/20 0.39
METAP2 P50579 1/20 0.39
PIM1 P11309 2/20 0.38
SRC P12931 1/20 0.38
GSK3A P49840 1/20 0.38
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
AKT1 P31749 2/20 0.36
PDK1 Q15118 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16020175 0.82 ESRRA (0.48) ALDH1A1MAPTSCN9AHTR2AHTR2C
SCHEMBL20817584 0.81 ALDH1A1 (0.53) ALDH1A1MAPTHTR2AHTR2CCOMT
SCHEMBL13144356 0.79 MAPT (0.50) ALDH1A1MAPTSCN9ACOMTKDM4E
SCHEMBL24893262 0.79 ALDH1A1 (0.43) ALDH1A1MAPTSCN9AHTR2AHTR2C
SCHEMBL16301302 0.79 DRD1 (0.49) ALDH1A1MAPTSCN9AHTR2AHTR2C
SCHEMBL16900307 0.77 ALDH1A1 (0.41) ALDH1A1MAPTSCN9AHTR2AHTR2C
SCHEMBL15248968 0.77 HTR2A (0.53) ALDH1A1MAPTSCN9AHTR2AHTR2C
SCHEMBL2274673 0.77 EGLN2 (0.44) ALDH1A1MAPTNISCHSCN9AHTR2A
SCHEMBL9911401 0.76 ALDH1A1 (0.54) ALDH1A1MAPTHTR2AHTR2CCOMT
SCHEMBL31148001 0.75 ALDH1A1 (0.42) ALDH1A1MAPTHTR2ACOMTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841331-B2 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-09-23 US disclosed
US-8841331-B2 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2014-09-23 US disclosed
US-20130203747-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION GILEAD SCIENCES, INC. (US) 2013-08-08 US disclosed
US-8338441-B2 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2012-12-25 US disclosed
US-8338441-B2 Inhibitors of human immunodeficiency virus replication GILEAD SCIENCES, INC. (US) 2012-12-25 US disclosed
WO-2010130034-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-18 WO disclosed
US-20100292227-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) 2010-11-18 US disclosed
US-20100292227-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BOEHRINGER INGLEHEIM INTERNATIONAL GMBH (DE) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292227-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION RTF2, REV1, RTF1 ALDH1A1 3054/4885MAPT 2761/4885NISCH 3036/4885
US-20130203747-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION RTF2, REV1, RTF1 ALDH1A1 3054/4885MAPT 2761/4885NISCH 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.